Only logged in customers who have purchased this product may leave a review.

Sermorelin
- Research Grade
- 99% Purity
- Third-Party Verified
Sermorelin
R899,00
Sermorelin is a synthetic growth hormone-releasing hormone (GHRH 1–29) analogue investigated for stimulating endogenous growth hormone release. It is intended for laboratory and scientific research purposes only.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Sermorelin
Sermorelin corresponds to the biologically active first 29 amino acids of endogenous GHRH and is researched for endocrine and IGF-1 signalling.
How It Works in Research
Sermorelin is researched for stimulating the body's natural release of growth hormone.
Research Applications
Growth hormone physiology IGF-1 Body composition Recovery Healthy ageing
Key Benefits
- Growth hormone research
- IGF-1 studies
- Recovery research
- Sleep investigations
Product Specifications
- Product Name|Sermorelin
- Alternate Chemical Name|GRF (1-29) amide; Sermorelin acetate
- Reference Strength|10mg
- Purity Standard|≥98% (HPLC)
- Appearance|White to off-white lyophilised powder
- Category|Growth Hormone Releasing Hormone (GHRH) Analogue
Research Information
- CAS Number|86168-78-7
- Molecular Formula|C149H246N44O42S
- Molecular Weight|3357.9 g/mol
- Storage|2–8°C after reconstitution
- Amino Acid Sequence|Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Mechanism of Action
Binds GHRH receptors in the anterior pituitary to stimulate physiological growth hormone secretion.
Key Research Characteristics
GHRH (1–29) analogue
Growth hormone secretagogue Endocrine research peptide Short-acting peptide
Potential Benefits in Research
Growth hormone research
- IGF-1 studies
- Recovery research
- Sleep investigations
Safety Profile
Injection-site irritation, flushing, headache, dizziness and nausea have been reported in research settings.
Research Applications
REFERENCE RECONSTITUTION INFORMATION
Sermorelin is supplied as a lyophilised peptide and should be reconstituted using bacteriostatic water before laboratory research use.
Always follow sterile preparation techniques when handling research peptides.
General Preparation
- Add 3.0mL bacteriostatic water slowly down the vial wall and gently swirl until fully dissolved. Do not shake the vial.
Sermorelin (10mg) - RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Sermorelin.
- Use a new sterile syringe.
- Rotate injection sites.
- Administer consistently.
- Document observations throughout the research protocol.
Reference Parameters (Dosing Protocol (3mL Reconstitution))
| Phase | Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 200mcg | 6 Units | 0.06mL |
| Weeks 3–4 | 300mcg | 9 Units | 0.09mL |
| Weeks 5–8 | 500mcg | 15 Units | 0.15mL |
Experimental Study Period
View Certificate of Analysis
View Certificate of Analysis Each batch of Sermorelin is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.

Reviews
There are no reviews yet.